by Team Small News | Apr 10, 2025 | Cipla, Pharma
Pharmaceutical company Cipla has announced the date for its earnings release for the fourth quarter and full year ended March 31, 2025. The company’s Board of Directors is scheduled to meet on Tuesday, May 13, 2025, to consider and approve the standalone and... by Team Small News | Apr 4, 2025 | Cipla, Pharma
However, I don’t see any content for me to summarize. The text appears to be a template with placeholders for dynamic data, but there is no actual content to summarize. Could you please provide the text with the dynamic data populated, or describe what the... by Team Small News | Apr 2, 2025 | Cipla, Lupin, Pharma
The latest survey on the Doxorubicin market has been conducted to provide a comprehensive analysis of the market’s performance, competitive environment, and market size. The report covers the period from 2019 to 2024 and provides a forecast till 2031. The market... by Team Small News | Mar 30, 2025 | Cipla, Pharma
Here is a summary of the content to 400 words: The Central Drugs Standard Control Organisation (CDSCO) has taken a significant step by advising Cipla, a leading pharmaceutical company, on the dosage of Fixed-Dose Combination (FDC) of Torsemide and Spironolactone. The... by Team Small News | Mar 26, 2025 | Cipla, Pharma
Cipla, a leading global pharmaceutical company, has signed an exclusive licensing agreement to expand its ophthalmology portfolio and global offerings. The agreement involves the acquisition of Formosa Pharmaceuticals’ US FDA-approved clobetasol propionate 0.05%... by Team Small News | Mar 22, 2025 | Biocon, Cipla, Lupin, Mankind, Natco, Pharma
Eli Lilly & Co. has launched its anti-obesity drug Mounjaro in India, making it the country’s first treatment of its kind. The drug, which is used to treat obesity and type-2 diabetes, works by activating hormones that help reduce the amount of sugar in the...